COVID-19: Developing Drugs and Biological Products for Treatment or Prevention QPS COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Read More »
COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for COVID-19 Related Drugs and Biological Products QPS COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for COVID-19 Related Drugs and Biological Products Read More »
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency QPS FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency Read More »
Policy for Coronavirus Disease-2019 Tests During The Public Health Emergency (Revised) QPS Policy for Coronavirus Disease-2019 Tests During The Public Health Emergency (Revised) Read More »
Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts QPS Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts Read More »
Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency QPS Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Read More »